找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Anti-Angiogenic Therapy in Ophthalmology; Andreas Stahl Book 2016 Springer International Publishing Switzerland 2016 Age-related macular d

[復(fù)制鏈接]
查看: 10411|回復(fù): 35
樓主
發(fā)表于 2025-3-21 17:57:46 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
期刊全稱(chēng)Anti-Angiogenic Therapy in Ophthalmology
影響因子2023Andreas Stahl
視頻videohttp://file.papertrans.cn/159/158318/158318.mp4
發(fā)行地址Explains why anti-angiogenic therapy is effective for various ocular diseases.Highlights the advantages and limitations of anti-angiogenic therapy.Written by established experts in their respective fi
學(xué)科分類(lèi)Essentials in Ophthalmology
圖書(shū)封面Titlebook: Anti-Angiogenic Therapy in Ophthalmology;  Andreas Stahl Book 2016 Springer International Publishing Switzerland 2016 Age-related macular d
影響因子This book provides a concise overview over the pathology of retinal angiogenic diseases and explains why anti-angiogenic therapy is effective in so many patients. The reader is guided through the various clinical indications for anti-angiogenic therapy and made aware of its merits as well as current challenges and limitations. It is explained how, since its introduction for the treatment of exudative age-related macular degeneration in 2006, anti-angiogenic therapy has revolutionized the way in which we treat a range of ocular diseases. All of the authors are established experts in their respective fields who share their extensive knowledge and clinical experience with the reader. This book is both a valuable introduction to anti-angiogenic therapy in ophthalmology and a day-to-day companion for all ophthalmologists seeing patients with some of the most prevalent retinal diseases..
Pindex Book 2016
The information of publication is updating

書(shū)目名稱(chēng)Anti-Angiogenic Therapy in Ophthalmology影響因子(影響力)




書(shū)目名稱(chēng)Anti-Angiogenic Therapy in Ophthalmology影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Anti-Angiogenic Therapy in Ophthalmology網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Anti-Angiogenic Therapy in Ophthalmology網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Anti-Angiogenic Therapy in Ophthalmology被引頻次




書(shū)目名稱(chēng)Anti-Angiogenic Therapy in Ophthalmology被引頻次學(xué)科排名




書(shū)目名稱(chēng)Anti-Angiogenic Therapy in Ophthalmology年度引用




書(shū)目名稱(chēng)Anti-Angiogenic Therapy in Ophthalmology年度引用學(xué)科排名




書(shū)目名稱(chēng)Anti-Angiogenic Therapy in Ophthalmology讀者反饋




書(shū)目名稱(chēng)Anti-Angiogenic Therapy in Ophthalmology讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶(hù)組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:15:12 | 只看該作者
板凳
發(fā)表于 2025-3-22 01:10:12 | 只看該作者
Retinal Vascular Development,evelopment is of interest for translational researchers and clinicians in order to develop preventive and interventional therapeutics for vascular eye diseases. In addition, the study of retinal vascular development has attracted significant interest in basic angiogenesis research due to high access
地板
發(fā)表于 2025-3-22 05:40:12 | 只看該作者
5#
發(fā)表于 2025-3-22 08:49:20 | 只看該作者
978-3-319-79580-5Springer International Publishing Switzerland 2016
6#
發(fā)表于 2025-3-22 14:36:48 | 只看該作者
Anti-Angiogenic Therapy in Ophthalmology978-3-319-24097-8Series ISSN 1612-3212 Series E-ISSN 2196-890X
7#
發(fā)表于 2025-3-22 19:28:25 | 只看該作者
8#
發(fā)表于 2025-3-23 01:12:07 | 只看該作者
https://doi.org/10.1007/978-3-540-69289-8 and developed world despite current screening and treatment guidelines. Originally named “retrolental fibroplasia,” ROP was first connected to premature birth in the 1940s and slightly later to oxygen supplementation in these premature infants. Today, an ever-improving understanding of ROP pathomec
9#
發(fā)表于 2025-3-23 04:42:14 | 只看該作者
Andreas StahlExplains why anti-angiogenic therapy is effective for various ocular diseases.Highlights the advantages and limitations of anti-angiogenic therapy.Written by established experts in their respective fi
10#
發(fā)表于 2025-3-23 09:37:35 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-26 05:15
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
玉田县| 泸州市| 合作市| 肥东县| 盐城市| 陵水| 商城县| 常德市| 霞浦县| 张家港市| 新河县| 永宁县| 涞水县| 郑州市| 大姚县| 象山县| 沾益县| 隆化县| 邯郸县| 马鞍山市| 昭通市| 定兴县| 乐亭县| 邯郸市| 关岭| 隆德县| 五家渠市| 遂溪县| 桂平市| 格尔木市| 礼泉县| 裕民县| 连南| 改则县| 刚察县| 嘉黎县| 玛曲县| 淳化县| 梅州市| 苍溪县| 雅安市|